Sanprobi IBS Drops 5 ml

The dietary supplement Sanprobi IBS is a high-quality product that contains the unique probiotic bacterial strain Lactobacillus plantarum 299v. It is primarily intended for people suffering from irritable bowel syndrome. The product has been extensively tested and has been shown to bring many benefits to those affected. The product has the advantage of being conveniently taken in the form of drops and can be stored at room temperature.

The irritable bowel syndrome (IBS) is a widespread functional disorder of the gastrointestinal tract. It is not known how this disease develops. Therapeutic options are also limited. Recent studies suggest that probiotics can influence the regulation of gastrointestinal motility.

In irritable bowel syndrome, the gut microflora is significantly altered. [1] Probiotic preparations can be a good option as antimicrobial agents for the treatment and prevention of intestinal infections. It has been shown that Lactobacillus plantarum 299v inhibits the adhesion of a pathogenic bacterium, Escherichia coli, to intestinal epithelial cells. [2]

A study was conducted in which IBS patients were recommended products with the bacterial strain Lactobacillus plantarum 299v. All patients supplemented with this strain reported cessation of abdominal pain and normalization of stool frequency (in the constipated form of irritable bowel syndrome). Lactobacillus plantarum 299v therefore appears to have a positive effect on the condition of IBS patients. [3]

In summary, the dietary supplement Sanprobi IBS is a high-quality product that contains the unique probiotic bacterial strain Lactobacillus plantarum 299v. This product was developed to replenish the gut microflora and support the therapy of patients with irritable bowel syndrome.

1 Kassinen A, Krogius-Kurikka L, Mäkivuokko H, Rinttilä T, Paulin L, Corander J, Malinen E, Apajalahti J, Palva A. The fecal microbiota of patients with irritable bowel syndrome differs significantly from that of healthy individuals. Gastroenterology. 2007 Jul;133(1):24-33. doi: 10.1053/j.gastro.2007.04.005. Epub 2007 Apr 14. PMID: 17631127.

2. Mack DR, Michail S, Wei S, McDougall L, Hollingsworth MA. Probiotics inhibit the adherence of enteropathogenic E. coli in vitro by inducing intestinal mucin gene expression. Am J Physiol. 1999 Apr;276(4):G941-50. doi: 10.1152/ajpgi.1999.276.4.G941. PMID: 10198338.

3 Niedzielin K, Kordecki H, Birkenfeld B. A controlled, double-blind, randomized study on the efficacy of Lactobacillus plantarum 299V in patients with irritable bowel syndrome. Eur J Gastroenterol Hepatol. 2001 Oct;13(10):1143-7. doi: 10.1097/00042737-200110000-00004. PMID: 11711768.